A 50% reduction in cyclosporine exposure in stable renal transplant recipients: renal function benefits.
Etienne
Isabelle
I
Department of Nephrology, Rouen University Hospital, and Inserm CIC 0204, Institute of Biomedical Research, University of Rouen, Rouen, France. Isabelle.Etienne@chu-rouen.fr
Toupance
Olivier
O
Bénichou
Jacques
J
Thierry
Antoine
A
Al Najjar
Azmi
A
Hurault de Ligny
Bruno
B
Le Meur
Yannick
Y
Westeel
Pierre-François
PF
Marquet
Pierre
P
François
Arnaud
A
Hellot
Marie-France
MF
Godin
Michel
M
D000293:Adolescent; D000328:Adult; D000368:Aged; D019540:Area Under Curve; D002102:Cadaver; D003404:Creatinine / Q000378:metabolism; D016572:Cyclosporine / Q000008:administration & dosage* / Q000493:pharmacokinetics; D005260:Female; D005500:Follow-Up Studies; D005919:Glomerular Filtration Rate; D006084:Graft Rejection / Q000517:prevention & control*; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics; D007676:Kidney Failure, Chronic / Q000628:therapy*; D007677:Kidney Function Tests; D016030:Kidney Transplantation / Q000401:mortality*; D008297:Male; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000493:pharmacokinetics; D011446:Prospective Studies; D015996:Survival Rate; D014018:Tissue Distribution; D014019:Tissue Donors; D016896:Treatment Outcome; D055815:Young Adult
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003404:Creatinine; D009173:Mycophenolic Acid